Novel quinoxaline-based survivin degraders overcome docetaxel-resistance in castration-resistant prostate cancer Article (Web of Science)

cited authors

  • Huang, Caoqinglong; Zheng, Xunzhen; Cui, Qingbin; Peery, Robert C.; Dong, Zizheng; Li, Xiaohong; Liu, Jing-Yuan; Zhang, Jian-Ting

publication date

  • March 1, 2026

webpage

published in

category

keywords

  • Degrader
  • Docetaxel resistance
  • Prostate cancer
  • Survivin dimerization
  • Synergism

volume

  • 85